Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer launches Besponsa in Japan

April 18, 2018

Mironid identifies novel PDE4 activators

April 18, 2018

Mission Therapeutics divulges new USP30 inhibitors

April 18, 2018

GlaxoSmithKline patents novel TrpV4 antagonists

April 18, 2018

BioAtla describes activity of anti-ROR2 antibody-drug conjugate BA-3021

April 18, 2018

Asahi Kasei Pharma initates phase III study of isavuconazole for deep-seated mycosis

April 18, 2018

FDA grants orphan drug designation to KL-1333 for inherited mitochondrial respiratory chain diseases

April 18, 2018

EPL-1410 demonstrates potential as immune-oncology therapeutic in preclinical models

April 18, 2018

Anavex to initiate phase II trial of ANAVEX2-73 in Parkinson's disease dementia

April 18, 2018

Third endometriosis program enters phase I under Evotec and Bayer alliance

April 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...